Keyphrases
Estrogen Receptor
100%
Estrogen Receptor Status
100%
Non-coding
100%
Single nucleotide Variant
100%
Estrogen Receptor Binding
100%
Chromatin Immunoprecipitation (ChIP)
36%
Sequence Data
27%
Breast Cancer
18%
High-level Expression
18%
Binding Site
18%
Breast Tumor
18%
Receptor-binding Domain
18%
GSTM1
18%
Breast Cancer Model
18%
Gene Expression
9%
Tumor
9%
Disease Progression
9%
Cancer Genome Atlas
9%
Computational Approach
9%
Clinical Data
9%
Functional Studies
9%
Omics Data
9%
Cistrome
9%
Atlas Data
9%
MACS®
9%
Clinical Prognosis
9%
Survival Analysis
9%
Carcinogen
9%
Luciferase Assay
9%
Altered Expression
9%
Computational pipeline
9%
De-implementation
9%
Non-coding Variants
9%
Transcriptomic Changes
9%
Phenotypic Change
9%
GSTM1 Gene
9%
MCF-7 Cells
9%
DNA Binding Sites
9%
Adjacent Genes
9%
Gene Expression Omnibus
9%
ChIP Assay
9%
Regulatory SNPs (rSNPs)
9%
Allele-specific Binding
9%
IGF1R Gene
9%
Biochemistry, Genetics and Molecular Biology
Single-Nucleotide Polymorphism
100%
Estrogen Receptor
100%
Receptor Binding
100%
Chromatin Immunoprecipitation
25%
Binding Site
25%
Gene Expression
12%
Allele
12%
Cancer Model
12%
Wild Type
6%
Promoter Region
6%
Transcriptomics
6%
DNA Binding Site
6%
Luciferase
6%
Tamsulosin
6%
Pharmacology, Toxicology and Pharmaceutical Science
Estrogen Receptor
100%
Binding Site
31%
Chromatin Immunoprecipitation
25%
Breast Cancer
25%
Breast Tumor
12%
Cancer Model
12%
Tamsulosin
6%
Malignant Neoplasm
6%
Carcinogen
6%
Disease Exacerbation
6%
Neoplasm
6%
Luciferase
6%
Diseases
6%